BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 38744979)

  • 1. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.
    Tropeano MP; Raspagliesi L; Bono BC; Baram A; Rossini Z; Franzini A; Navarria P; Clerici E; Bellu L; Simonelli M; Scorsetti M; Riva M; Politi LS; Pessina F
    Acta Neurochir (Wien); 2024 Apr; 166(1):196. PubMed ID: 38676720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAPNO efforts in Brain Tumour Outcomes.
    Virani QU; Javed Z; Shamim MS
    J Pak Med Assoc; 2024 May; 74(5):1005-1006. PubMed ID: 38783459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy.
    Rykkje AM; Carlsen JF; Larsen VA; Skjøth-Rasmussen J; Christensen IJ; Nielsen MB; Poulsen HS; Urup TH; Hansen AE
    Sci Rep; 2024 May; 14(1):10985. PubMed ID: 38744979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study.
    Bjorland LS; Mahesparan R; Fluge Ø; Gilje B; Dæhli Kurz K; Farbu E
    Neurooncol Adv; 2023; 5(1):vdad126. PubMed ID: 37868696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of Early Postoperative MRI following Primary Glioblastoma Surgery-A Retrospective Study of Contrast Enhancements in 311 Patients.
    Rykkje AM; Larsen VA; Skjøth-Rasmussen J; Nielsen MB; Carlsen JF; Hansen AE
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups.
    Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Versyck G; Jessurun CAC; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Tewarie RN; Smith TR; Dirven CMF; De Vleeschouwer S; Vincent AJPE; Broekman MLD
    Neuro Oncol; 2023 May; 25(5):958-972. PubMed ID: 36420703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.
    Karschnia P; Young JS; Dono A; Häni L; Sciortino T; Bruno F; Juenger ST; Teske N; Morshed RA; Haddad AF; Zhang Y; Stoecklein S; Weller M; Vogelbaum MA; Beck J; Tandon N; Hervey-Jumper S; Molinaro AM; Rudà R; Bello L; Schnell O; Esquenazi Y; Ruge MI; Grau SJ; Berger MS; Chang SM; van den Bent M; Tonn JC
    Neuro Oncol; 2023 May; 25(5):940-954. PubMed ID: 35961053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival.
    Behling F; Rang J; Dangel E; Noell S; Renovanz M; Mäurer I; Schittenhelm J; Bender B; Paulsen F; Brendel B; Martus P; Gempt J; Barz M; Meyer B; Tatagiba M; Skardelly M
    Front Oncol; 2022; 12():755430. PubMed ID: 35251956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgically Induced Contrast Enhancements on Intraoperative and Early Postoperative MRI Following High-Grade Glioma Surgery: A Systematic Review.
    Rykkje AM; Li D; Skjøth-Rasmussen J; Larsen VA; Nielsen MB; Hansen AE; Carlsen JF
    Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
    Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis.
    Revilla-Pacheco F; Rodríguez-Salgado P; Barrera-Ramírez M; Morales-Ruiz MP; Loyo-Varela M; Rubalcava-Ortega J; Herrada-Pineda T
    Medicine (Baltimore); 2021 Jun; 100(25):e26432. PubMed ID: 34160432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution.
    Abedi AA; Grunnet K; Christensen IJ; Michaelsen SR; Muhic A; Møller S; Hasselbalch B; Poulsen HS; Urup T
    Front Oncol; 2021; 11():597587. PubMed ID: 33718145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
    Weller M; van den Bent M; Preusser M; Le Rhun E; Tonn JC; Minniti G; Bendszus M; Balana C; Chinot O; Dirven L; French P; Hegi ME; Jakola AS; Platten M; Roth P; Rudà R; Short S; Smits M; Taphoorn MJB; von Deimling A; Westphal M; Soffietti R; Reifenberger G; Wick W
    Nat Rev Clin Oncol; 2021 Mar; 18(3):170-186. PubMed ID: 33293629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging evaluation of brain glioma before postoperative radiotherapy.
    Sui Z; Zhang X; Li H; Xu D; Li G
    Clin Transl Oncol; 2021 Apr; 23(4):820-826. PubMed ID: 32857338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nomogram Model Predicting Overall Survival and Guiding Clinical Decision in Patients With Glioblastoma Based on the SEER Database.
    Li H; He Y; Huang L; Luo H; Zhu X
    Front Oncol; 2020; 10():1051. PubMed ID: 32676458
    [No Abstract]   [Full Text] [Related]  

  • 16. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
    Wen PY; Weller M; Lee EQ; Alexander BM; Barnholtz-Sloan JS; Barthel FP; Batchelor TT; Bindra RS; Chang SM; Chiocca EA; Cloughesy TF; DeGroot JF; Galanis E; Gilbert MR; Hegi ME; Horbinski C; Huang RY; Lassman AB; Le Rhun E; Lim M; Mehta MP; Mellinghoff IK; Minniti G; Nathanson D; Platten M; Preusser M; Roth P; Sanson M; Schiff D; Short SC; Taphoorn MJB; Tonn JC; Tsang J; Verhaak RGW; von Deimling A; Wick W; Zadeh G; Reardon DA; Aldape KD; van den Bent MJ
    Neuro Oncol; 2020 Aug; 22(8):1073-1113. PubMed ID: 32328653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study.
    Byun J; Kim YH; Nam SJ; Park JE; Cho YH; Kim HS; Hong SH; Kim JH; Kim SJ; Kim CJ
    World Neurosurg; 2019 Jan; 121():e858-e866. PubMed ID: 30315970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response Assessment in Neuro-Oncology Clinical Trials.
    Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
    J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.